Zuclomiphene Safely Eases Hot Flashes Linked to ADT Use, Phase 2 Trial Reports
News
Interim Phase 2 trial results show that Veru‘s experimental treatment zuclomiphene citrate is well-tolerated and significantly reduces hot flashes in advanced prostate cancer patients using androgen deprivation therapy (ADT). These ... Read more